You are here
- Home
- Therapy Areas
- Oncology/Infection
Protection of Ovarian Function with Goserelin Acetate in Premenopausal Early Breast Cancer Patients Undergoing Adjuvant Chemotherapy: An Open Label, Randomised, Multi-Centre, Phase IIIb Study
- Disease
- breast cancer
- Drug Name
- Zoladex
- Generic Name
- goserelin acetate
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- IIIb
- Start Date
- Apr 30, 2009
- Study Name
- D8664L00012
- Study Id
- D8664L00012
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
